Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Results Summary of basic information of existing GLP-1RA in China As of December 2023, there were 9 drugs in the GLP-1RA class approved for the treatment of T2DM in China, including Semaglutide injection, Liraglutide injection, Dulaglutide injection, Polyethylene glycol loxenatide injection, Insulin degludec and liraglutide injection, Exenatide injection, Benaglutide injection, Exenatide microsphees for injection, and Lixisenatide injection [21, 22]
Qu et al
Its defining property is receptor selectivity at typical research doses it produces minimal cortisol, prolactin, or ACTH elevation, distinguishing it from earlier GHRPs like GHRP-6 or GHRP-2
Integrated vs
US$ 27.85
.png)
US$ 22.34
US$ 20.01
US$ 21.70
US$ 28.26
US$ 24.36
